324 related articles for article (PubMed ID: 24512328)
1. Is murine gammaherpesvirus-68 (MHV-68) a suitable immunotoxicological model for examining immunomodulatory drug-associated viral recrudescence?
Aligo J; Walker M; Bugelski P; Weinstock D
J Immunotoxicol; 2015; 12(1):1-15. PubMed ID: 24512328
[TBL] [Abstract][Full Text] [Related]
2. Murine gammaherpesvirus-68 (MHV-68) is not horizontally transmitted amongst laboratory mice by cage contact.
Aligo J; Brosnan K; Walker M; Emmell E; Mikkelsen SR; Burleson GR; Burleson FG; Volk A; Weinstock D
J Immunotoxicol; 2015; 12(4):330-41. PubMed ID: 25412621
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic γ Herpesviruses EBV and HHV8 in Kidney Transplantation.
Le J
Semin Nephrol; 2016 Sep; 36(5):362-371. PubMed ID: 27772621
[TBL] [Abstract][Full Text] [Related]
4. The Immune Response to Epstein Barr Virus and Implications for Posttransplant Lymphoproliferative Disorder.
Martinez OM; Krams SM
Transplantation; 2017 Sep; 101(9):2009-2016. PubMed ID: 28376031
[TBL] [Abstract][Full Text] [Related]
5. Vaccine prospect of Kaposi sarcoma-associated herpesvirus.
Wu TT; Qian J; Ang J; Sun R
Curr Opin Virol; 2012 Aug; 2(4):482-8. PubMed ID: 22795202
[TBL] [Abstract][Full Text] [Related]
6. Murid herpesvirus 4 (MuHV-4, prototype strain MHV-68) as an important model in global research of human oncogenic gammaherpesviruses.
Mistríková J; Briestenská K
Acta Virol; 2020; 64(2):167-176. PubMed ID: 32551785
[TBL] [Abstract][Full Text] [Related]
7. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.
Hart M; Thakral B; Yohe S; Balfour HH; Singh C; Spears M; McKenna RW
Am J Surg Pathol; 2014 Nov; 38(11):1522-9. PubMed ID: 25007145
[TBL] [Abstract][Full Text] [Related]
8. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
[TBL] [Abstract][Full Text] [Related]
9. Rewiring of the Host Cell Metabolome and Lipidome during Lytic Gammaherpesvirus Infection Is Essential for Infectious-Virus Production.
Clark SA; Vazquez A; Furiya K; Splattstoesser MK; Bashmail AK; Schwartz H; Russell M; Bhark SJ; Moreno OK; McGovern M; Owsley ER; Nelson TA; Sanchez EL; Delgado T
J Virol; 2023 Jun; 97(6):e0050623. PubMed ID: 37191529
[TBL] [Abstract][Full Text] [Related]
10. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
Callahan J; Pai S; Cotter M; Robertson ES
Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
[TBL] [Abstract][Full Text] [Related]
11. Reflections on Epstein-Barr virus: some recently resolved old uncertainties.
Epstein MA
J Infect; 2001 Aug; 43(2):111-5. PubMed ID: 11676516
[TBL] [Abstract][Full Text] [Related]
12. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
Dolcetti R
Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317
[TBL] [Abstract][Full Text] [Related]
13. Post-transplant lymphoproliferative disorder associated with immunosuppressive therapy for renal transplantation in rhesus macaques (Macaca mulatta).
Page EK; Courtney CL; Sharma P; Cheeseman J; Jenkins JB; Strobert E; Knechtle SJ
Exp Toxicol Pathol; 2013 Nov; 65(7-8):1019-24. PubMed ID: 23578881
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-DNA load monitoring late after lung transplantation: a surrogate marker of the degree of immunosuppression and a safe guide to reduce immunosuppression.
Bakker NA; Verschuuren EA; Erasmus ME; Hepkema BG; Veeger NJ; Kallenberg CG; van der Bij W
Transplantation; 2007 Feb; 83(4):433-8. PubMed ID: 17318076
[TBL] [Abstract][Full Text] [Related]
15. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
16. CD8+ T cell immunity to Epstein-Barr virus and Kaposi's sarcoma-associated herpes virus.
Hislop AD; Sabbah S
Semin Cancer Biol; 2008 Dec; 18(6):416-22. PubMed ID: 19007888
[TBL] [Abstract][Full Text] [Related]
17. The Epstein-Barr virus and post-transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis.
Tanner JE; Alfieri C
Transpl Infect Dis; 2001 Jun; 3(2):60-9. PubMed ID: 11395971
[TBL] [Abstract][Full Text] [Related]
18. Infectious agents in human cancers: lessons in immunity and immunomodulation from gammaherpesviruses EBV and KSHV.
Taylor GS; Blackbourn DJ
Cancer Lett; 2011 Jun; 305(2):263-78. PubMed ID: 21470769
[TBL] [Abstract][Full Text] [Related]
19. Epstein-barr virus- and Kaposi sarcoma-associated herpesvirus-related malignancies in the setting of human immunodeficiency virus infection.
Pinzone MR; Berretta M; Cacopardo B; Nunnari G
Semin Oncol; 2015 Apr; 42(2):258-71. PubMed ID: 25843730
[TBL] [Abstract][Full Text] [Related]
20. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas?
Lazzi S; Bellan C; Amato T; Palummo N; Cardone C; D'Amuri A; De Luca F; Beyanga M; Facchetti F; Tosi P; Leoncini L
Hum Pathol; 2006 Jan; 37(1):23-31. PubMed ID: 16360412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
